Cargando…
Fibroblast growth factor 21 is an independent predictor of prevalent and incident obstructive sleep apnea
Fibroblast growth factor 21 (FGF21) is a metabolic regulator and a potential biomarker of metabolic diseases. Limited data are available on the association between FGF21 and obstructive sleep apnea (OSA), which is considered as a manifestation of metabolic syndrome. In the present cross-sectional an...
Autores principales: | Huang, Weijun, Zhang, Jingyu, Zou, Jianyin, Wang, Xiaoting, Xu, Huajun, Guan, Jian, Yi, Hongliang, Liu, Suru, Yin, Shankai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926096/ https://www.ncbi.nlm.nih.gov/pubmed/36798439 http://dx.doi.org/10.1016/j.isci.2023.105985 |
Ejemplares similares
-
Prevalence, characteristics, and respiratory arousal threshold of positional obstructive sleep apnea in China: a large scale study from Shanghai Sleep Health Study cohort
por: Huang, Weijun, et al.
Publicado: (2022) -
A retrospective study: does upper airway morphology differ between non-positional and positional obstructive sleep apnea?
por: Jiao, Xiao, et al.
Publicado: (2017) -
Effect of Interaction Between Slow Wave Sleep and Obstructive Sleep Apnea on Insulin Resistance: A Large-Scale Study
por: Huang, Weijun, et al.
Publicado: (2021) -
Effect of the Interaction between Obstructive Sleep Apnea and Lipoprotein(a) on Insulin Resistance: A Large-Scale Cross-Sectional Study
por: Liu, Yupu, et al.
Publicado: (2019) -
Excessive daytime sleepiness, metabolic syndrome, and obstructive sleep apnea: two independent large cross-sectional studies and one interventional study
por: Li, Xinyi, et al.
Publicado: (2019)